This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Today's Health Winners and Losers

Shares of Kinetic Concepts (KCI) were among the worst-performing health-related stocks Monday, falling 8% after the medical-equipment maker posted mixed fourth-quarter results and forecast 2006 sales below Wall Street's expectation.

For the fourth quarter, the company earned $46.4 million, or 64 cents a share, on sales of $322 million. Analysts polled by Thomson First Call expected earnings of 61 cents a share and sales of $336.7 million. During the year-earlier quarter, the company earned $34.2 million, or 47 cents a share, on sales of $273.7 million.

Looking ahead, Kinetic Concepts sees 2006 earnings of $190 million to $200 million, or $2.59 to $2.69 a share, on sales of $1.34 billion to $1.39 billion. The earnings forecast includes 10 cents to 11 cents a share in stock-based compensation expense. Analysts' estimates, which don't include the stock-based compensation costs, call for earnings of $2.66 a share and sales of $1.41 billion. Shares were trading down $3.05 to $39.65.

Shares of Omnicare (OCR - Get Report) tumbled 10% after an analyst downgrade and a reported raid on some of the company's offices. According to a Cincinnati Enquirer report Friday, the Michigan attorney general's office said its agents led a raid into Omnicare's offices in Livonia, Mich., and other unspecified cities, but didn't disclose the reason for the searches. Stifel Nicolaus downgraded Omnicare to hold from buy, citing the report. In a statement Monday, Omnicare said it doesn't comment on or confirm government reviews or inquiries. Shares of Omnicare, a drug supplier to nursing homes, fell $5.62 to $49.43.

Kensey Nash (KNSY) fell 5% after the company posted mixed second-quarter results and offered soft guidance. For the quarter ended Dec. 31, the medical-device company reported a loss of $555,860, or 5 cents a share, on total sales of $13.6 million. Excluding one-time items and stock-based compensation costs, the company earned $1.4 million, or 12 cents a share. Analysts expected earnings of 10 cents a share on this basis, with sales of $14.2 million. During the year-earlier period, the company earned $3.3 million, or 27 cents a share, on sales of $15.2 million.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs